Checking PSA levels following treatment is crucial among patients with nonmetastatic, unfavorable risk prostate cancer, according to the co-author of a recent study. Prostate-specific antigen (PSA) ...
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...
KPG-121, a novel cereblon modulator, in patients with metastatic castration resistant prostate cancer: Results of a phase I multiple ascending dose study. Baseline PSMA PET/CT as a predictive ...
Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...
It’s incredible news that all black men aged 45 to 74 will be offered to take part in prostate screening trials. There has ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results